Item 7.01. Regulation FD Disclosure.
Savara has updated its corporate presentation, which is available on the
Investor Relations page of Savara's website at
https://savarapharma.com/investors/press-releases. A copy of the presentation is
furnished as Exhibit 99.1 to this Current Report on Form 8-K. Savara undertakes
no duty or obligation to update or revise the information contained in this
presentation, although it may do so from time to time. Any such updates may be
made through the Investor Relations page of the Savara website, the filing of
other reports or documents with the
Savara may announce material information about its finances, product candidates,
clinical trials and other matters to its investors using the Investor Relations
page of the Savara website (referenced above),
The information in Item 7.01 in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Savara Corporate Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source